Discounted Cash Flow Rating

Strong Buy

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Strong Buy

Price to Earnings Rating

Buy

Analyst Rating

Buy

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Strong Buy

Standard Deviation

Strong Sell

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Neutral

Wall Street Data Solutions Rating

Neutral

B

Enviva Inc. (EVA)

Lumber & Wood Products (no Furniture)

https://www.envivabiomass.com

Enviva Inc develop, construct, acquire, and own and operate, fully contracted wood pellet production plants where the company aggregate a natural resource, wood fiber, and process it into dry, densified, uniform pellets that can be effectively stored and transported around the world. The company sells term, take-or-pay off-take contracts with creditworthy customers in the United Kingdom, the European Union, and Japan, who use pellets to displace coal and other fossil fuels to generate power and heat as part of their efforts to accelerate the energy transition away from conventional energy sources. The company derive a majority of revenues from customers in Europe.

7272 WISCONSIN AVE., SUITE 1800
BETHESDA, MD

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

04/29/2015

Market Cap

42,455,555

Shares Outstanding

74,500,000

Weighted SO

74,496,537

Total Employees

N/A

Upcoming Earnings

05/29/2024

Similar Tickers

UFPI --.--%

SSD --.--%

IFSPF --.--%

CFPZF --.--%

WFG --.--%

STLJF --.--%

SVCBF --.--%

WFSTF --.--%

Beta

0.8130

Last Div

0.0000

Range

0.254-10.97

Chg

0.0009

Avg Vol

357916

Mkt Cap

42455555

Exch

NYSE

Country

US

Phone

301 657 5560

DCF Diff

18.2948

DCF

64.3348

Div Yield

0.0000

P/S

0.0476

EV Multiple

50.2830

P/FV

0.1369

Div Yield %

0.0000

P/E

-0.1646

PEG

-0.0092

Payout

-0.2215

Current Ratio

1.4157

Quick Ratio

1.0566

Cash Ratio

0.5883

DSO

97.6398

DIO

86.0172

Op Cycle

183.6569

DPO

21.3508

CCC

162.3061

Gross Margin

0.0845

Op Margin

-0.1388

Pretax Margin

-0.2889

Net Margin

-0.2892

Eff Tax Rate

-0.0007

ROA

-0.0891

ROE

-0.8865

ROCE

-0.0525

NI/EBT

1.0008

EBT/EBIT

2.0813

EBIT/Rev

-0.1388

Debt Ratio

0.6672

D/E

6.2296

LT Debt/Cap

0.8607

Total Debt/Cap

0.8617

Int Coverage

-0.9077

CF/Debt

-0.0133

Equity Multi

9.3362

Rec Turnover

3.7382

Pay Turnover

17.0954

Inv Turnover

4.2433

FA Turnover

0.5068

Asset Turnover

0.3081

OCF/Share

-0.3438

FCF/Share

-3.1986

Cash/Share

4.2339

OCF/Sales

-0.0287

FCF/OCF

9.3029

CF Coverage

-0.0133

ST Coverage

-1.5669

CapEx Coverage

-0.1204

Div&CapEx Cov

-0.0949

P/BV

0.1369

P/B

0.1369

P/S

0.0476

P/E

-0.1646

P/FCF

-0.1783

P/OCF

-1.6575

P/CF

-1.6575

PEG

-0.0092

P/S

0.0476

EV Multiple

50.2830

P/FV

0.1369

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. May 31, 01:05 New Data from Teva Shows Substantial Rates of Undertreated Tardive Dyskinesia in Long-Term Care Settings at Psych Congress Elevate 2025 GlobeNewswire Inc. May 31, 01:00 Teva Presents Latest Schizophrenia Portfolio Data Including Real-World Outcomes with UZEDY® (risperidone) Showing Lower Rates of and Longer Time to Relapse Compared to Oral Treatment Options and New Phase 3 SOLARIS Data Showing No Incidence of PDSS with T The Motley Fool Feb 16, 14:45 This Stock Is Already Up by 55% in 2025: Is It Too Late to Buy? GlobeNewswire Inc. Jan 14, 03:26 Teva gibt Zusammenarbeit zur Vermarktung des Formycon Biosimilar-Kandidaten für Eylea® (Aflibercept) in großen Teilen Europas und in Israel bekannt GlobeNewswire Inc. Jan 14, 03:26 Teva annonce un partenariat en vue de commercialiser le candidat biosimilaire de Formycon à Eylea® (aflibercept) dans la majeure partie de l’Europe et en Israël Benzinga Nov 05, 02:02 Jim Cramer Keeps Recommending Tesla Because He Loves 'Space Stuff,' But He's Not Keen On Ford: 'I Can't Recommend The Stock' GlobeNewswire Inc. Aug 26, 00:30 Global Acetaminophen-Opioid Combination Market Growth Accelerating Due to an Impressive USD 4,522.6 Million by 2034 Increased Usage in Cancer-Related Pain: Future Market Insights Benzinga Jul 06, 16:15 DeSantis Is Less Popular Than Florida's Cannabis Amendment, Wealthy Attorney John Morgan Eyes Gubernatorial Run - Benzinga GlobeNewswire Inc. Jul 03, 05:00 Global Allergy Therapeutics Market Size To Exceed USD 42.5 Billion By 2033 | CAGR Of 6.29% - GlobeNewswire Benzinga Jan 23, 07:44 Enphase Energy To Rally Over 35%? Here Are 10 Top Analyst Forecasts For Tuesday GlobeNewswire Inc. Jan 22, 16:30 Evaxion Announces Completion of ADS Ratio Change The Motley Fool Jan 10, 05:21 3 No-Brainer Stocks to Buy With $20 Right Now GlobeNewswire Inc. Jan 09, 04:43 Evaxion annonce un plan visant à mettre en Å“uvre la modification du ratio de ses ADS GlobeNewswire Inc. Jan 09, 04:43 Evaxion kündigt Plan zur Änderung des ADS-Verhältnisses an GlobeNewswire Inc. Jan 08, 08:30 Evaxion Announces Plan to Implement ADS Ratio Change GlobeNewswire Inc. Dec 22, 15:13 Evaxion Biotech gibt Abschluss einer Privatplatzierung bekannt GlobeNewswire Inc. Dec 22, 15:13 Clôture du financement par placement privé pour Evaxion Biotech GlobeNewswire Inc. Dec 22, 15:13 Evaxion Biotech gibt Abschluss einer Privatplatzierung bekannt GlobeNewswire Inc. Dec 22, 15:13 Clôture du financement par placement privé pour Evaxion Biotech GlobeNewswire Inc. Dec 21, 16:30 Evaxion Biotech Announces Closing of Private Placement

Revenue Product Segmentation

Dividend History

Cash Value Ex-Dividend Date Declaration Date Record Date Pay Date
0.90 02/17/2023 02/08/2023 02/21/2023 02/24/2023
0.90 11/10/2022 11/02/2022 11/14/2022 11/25/2022
0.90 08/12/2022 08/03/2022 08/15/2022 08/26/2022
0.90 05/13/2022 05/04/2022 05/16/2022 05/27/2022
0.86 02/11/2022 02/03/2022 02/14/2022 02/25/2022
0.84 11/12/2021 11/03/2021 11/15/2021 11/26/2021
0.82 08/12/2021 07/27/2021 08/13/2021 08/27/2021
0.78 05/13/2021 04/27/2021 05/14/2021 05/28/2021
0.78 02/11/2021 01/27/2021 02/15/2021 02/26/2021
0.78 11/12/2020 10/30/2020 11/13/2020 11/27/2020
0.76 08/14/2020 08/05/2020 08/17/2020 08/28/2020
0.68 05/14/2020 04/29/2020 05/15/2020 05/29/2020
0.68 02/13/2020 01/29/2020 02/14/2020 02/28/2020
0.67 11/14/2019 10/30/2019 11/15/2019 11/29/2019
0.66 08/14/2019 07/31/2019 08/15/2019 08/29/2019
0.64 05/17/2019 05/08/2019 05/20/2019 05/29/2019
0.64 02/14/2019 01/30/2019 02/15/2019 02/28/2019
0.64 11/14/2018 10/31/2018 11/15/2018 11/29/2018
0.63 08/14/2018 08/01/2018 08/15/2018 08/29/2018
0.62 05/14/2018 05/03/2018 05/15/2018 05/29/2018
0.62 02/14/2018 01/31/2018 02/15/2018 02/28/2018
0.62 11/14/2017 11/02/2017 11/15/2017 11/29/2017
0.57 08/11/2017 08/02/2017 08/15/2017 08/29/2017
0.56 05/16/2017 05/03/2017 05/18/2017 05/30/2017
0.54 02/13/2017 02/01/2017 02/15/2017 02/28/2017
0.53 11/09/2016 11/03/2016 11/14/2016 11/29/2016
0.52 08/11/2016 08/03/2016 08/15/2016 08/29/2016
0.51 05/12/2016 05/04/2016 05/16/2016 05/27/2016
0.46 02/12/2016 02/05/2016 02/17/2016 02/29/2016
0.44 11/13/2015 10/29/2015 11/17/2015 11/27/2015
0.26 08/12/2015 07/29/2015 08/14/2015 08/31/2015